Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

Kil- The market will only die out for the shorts if and when Damaj quits floating shares. I don't think you have looked at the last 4-5 quarters. Each quarter has had an incease in shares outstanding. With the authorization of over 300M authorized shares, what do you think? I don't care about the additional shares they will have to cough up if and when Fluticare does get approved (not this year) and maybe not in Q1. However, Let's see how many new shares outstanding show up in the Q4 and then the Q1. Damaj significantly inceased the shares outstanding at Apricus. When he left, the company was headed downhill after he did the RS.

Increasing shares does cause a dilutive effect. If he runs the shares outstanding up to 200M, he will need about $100M in revenues to offset.